press meet: biocon biologics to acquire viatris' biosimilars business for global leadership
Published 2 years ago • 287 plays • Length 23:22Download video MP4
Download video MP3
Similar videos
-
2:14
biocon biologics to acquire viatris global biosimilars assets for upto usd 3.335 bn in stock & cash
-
54:02
biocon biologics' management on acquiring biosimilars business of viatris
-
10:03
biocon biologics to close viatris deal soon, ipo plan likely in 12-24 months
-
2:48
our acquisition of viatris business has been 'spooking the indian investor,' biotechnology firm says
-
9:33
press meet: biocon biologics and serum institute life sciences announce strategic alliance (part 1)
-
2:08
biocon biologics is well-placed to take advantage of opportunities in the biosimilars space: ceo
-
12:25
biocon biologics q3: biosimilars revenue up 54%, ebitda up 53% yoy
-
10:35
biocon's siddharth mittal speaks on selling stake in syngene & viatris biologics biz acquisition
-
14:48
viatris stock analysis ($vtrs) | is it a buy?
-
13:31
interview: from bench to business to patient
-
57:53
rediscovery of extracellular vesicles – from labeling, dosage, size to biodistribution and function
-
1:44
biocon 2024 | promo video
-
2:35
biocon biologics: enabling equitable access to affordable healthcare
-
2:35
strong biosimilar growth powers biocon | trading hour | cnbc tv18
-
10:32
axis capital conference 2019: biocon on their biosimilars business
-
50:52
press meet: biocon biologics and serum institute life sciences announce strategic alliance (part 2)
-
7:26
biocon biologies ipo, debt reduction strategy & more | kiran mazumdar-shaw & peter bains
-
20:38
will viatris deal inject fresh momentum into biocon's biz? | pharma | business standard
-
3:12
biocon biologics acquires viatris' biosimilars business in $3.3 bn deal
-
13:12
arm meeting on the med 2023: biocentriq global showcase
-
2:11
insulin glargine: journey to the usfda approval